Light Mode
$0.3850 ↓ -0.0192 (-4.75%) Trading Down from the previous close of $0.4042, and at the day’s high of $0.3850
-0.18 (-31.25%) / 6M
Momentum, market sentiment, and recent alerts
ATXI reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -46.4%.
No alerts for ATXI in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.